Chemistry and Crazy Ideas: Getting to Know Ali Tavassoli
August 27, 2025
Learning more about the people behind this year’s Power List: Ali Tavassoli, Chief Scientific Officer of Curve Therapeutics
10 min read
False
Advertisement
Interviews
From Pilot Dreams to Drug Development: Interviewing Subas Sakya
By Stephanie Vine
August 26, 2025
We sit down with the Chief Scientific Officer of BioDuro to find out what he wanted to be as a child and how he came to love drug development.
10 min read
Formulating for Safety: How to Minimize Nitrosamine Risk
August 15, 2025
What should the industry do to tackle nitrosamines? It comes down to excipient selection, process control, and predictive tools.
7 min read
What's the Latest in the US with Pharma and Trump?
By Rob Coker
August 12, 2025
Industry expert Audrey Greenberg gives the latest update on US pharma, Trump policies, and how pharma supply chains are affected
2 min read
From Manual to Metadata: How Novo Nordisk is Rewiring Clinical Trials
July 30, 2025
Tech companies and drug developers are aiming for faster, more efficient, completely compliant clinical trials through the use of AI – and there’s no such thing as too much data.
4 min read
Improving Immunotherapies With Digital Monitoring
July 24, 2025
An expert explains how digital technologies are helping to prevent cytokine release syndrome from immunotherapies.
6 min read
Improving Access to Diabetes Treatment
July 22, 2025
The Access to Medicine Foundation has reported on a string of strategies designed to improve access to diabetes treatments for children and young people in LMICs.
12 min read
Can a Spider Venom-Inspired Peptide Revolutionize Sexual Dysfunction Medicine?
July 7, 2025
Another Day Pharma tells us how a spider venom-derived topical peptide might be able to help those affected by erectile dysfunction and female sexual dysfunction.
11 min read
Making Solid Progress: Sitting Down With 2025 Power Lister John Maher
July 4, 2025
Following another appearance in our 2025 Power List, we discuss the journey of John Maher, co-founder and CSO, Leucid Bio, from Michel Sadelain’s New York lab to King’s College London.
5 min read
New Weight-Loss Drug Aims for Results Without Harsh GI Effects
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
